Mometasonfuroaat Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroaat Teva, is a corticosteroid (topical glucocorticoid) presented as a topical formulation for skin use. It is prescribed to reduce inflammation and itching in various dermatologic conditions such as psoriasis, atopic dermatitis, contact dermatitis and eczema.

GNH USA supplies Mometasonfuroaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a potent topical glucocorticoid that modulates inflammatory pathways in skin disorders. It is indicated for: - Psoriasis: decreases plaque thickness, scaling and erythema. - Atopic dermatitis: alleviates itching, redness and edema. - Contact dermatitis: reduces allergic or irritant‑mediated inflammation. - Eczema: controls chronic inflammation and improves barrier function.

Mometasone furoate may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation or burning sensation at the application site. - Pruritus or mild itching. - Dryness or peeling of the treated skin. - Folliculitis or acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Hypopigmentation or depigmented patches. - Allergic contact dermatitis. - Secondary bacterial, fungal or viral skin infections. - Systemic corticosteroid effects such as adrenal suppression. - Severe hypersensitivity reactions including angioedema.

Before initiating therapy, consider the following precautions: - Assess severity: limit use to mild‑moderate disease and avoid prolonged continuous application. - Infected skin: do not apply to areas with bacterial, fungal or viral infection unless directed by a clinician. - Surface area: avoid treating large body surface areas or using occlusive dressings without medical supervision. - Duration: use the lowest effective potency for the shortest period necessary. - Pediatric use: apply cautiously in children, monitoring for growth‑related effects. - Store at room temperature: keep in the original container, protect from moisture and light.

Mometasone furoate can interact with other agents that affect corticosteroid metabolism or skin integrity.

Major Interactions (Avoid): - Systemic corticosteroids: may increase systemic exposure and risk of adrenal suppression. - Potent CYP3A4 inhibitors (e.g., ketoconazole): could raise local drug concentration. - Immunosuppressants: heightened risk of skin infection.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topicals: potential for increased irritation. - Concurrent use of other topical steroids: additive glucocorticoid effect. - Photosensitizing agents (e.g., retinoids): increased photosensitivity risk.